Levofloxacin-associated tendon disorders: Sex-, age-, and route-specific disproportionality analysis using FAERS and JADER
Toshihisa Nakashima, Yoshihiro Noguchi, Rikuto Masuda, Tomoaki Yoshimura · 2026
Read Levofloxacin-associated tendon disorders: Sex-, age-, and route-specific disproportionality analysis using FAERS and JADER by Toshihisa Nakashima, Yoshihiro Noguchi, Rikuto Masuda, Tomoaki Yoshimura (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358427.txt.
Description
Toshihisa Nakashima and colleagues published a 2026 drug safety analysis in PLOS ONE on tendon injuries linked to levofloxacin, a widely used antibiotic. Tendon damage is a known rare risk of this drug family, but patterns by sex, age, and how the drug is given were poorly mapped in Japan. The team mined two large spontaneous reporting databases, one American and one Japanese, covering five related antibiotics.
All five drugs showed warning signals in the American data, but only levofloxacin showed strong, consistent signals in both Japanese sources. The signal was much stronger in men, especially those aged seventy and older, and stronger for the oral form than for intravenous use. Most tendon events were reported within about two weeks of starting the drug. The authors urge Japanese clinicians to prescribe levofloxacin cautiously for older men and to watch early for tendon pain.
Catalog record
| CREATOR | Toshihisa Nakashima, Yoshihiro Noguchi, Rikuto Masuda, Tomoaki Yoshimura |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42787 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |